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Possible Role for Acetylcholine as a Neurotransmitter in Canine 
Penile Erection 
Christian Stief1, Wolfgang Diederichs, Francois Benard, Ruud Bosch, SherifAboseif, Tom F. Lue, 
Emil A. Tanagho 
Department of Urology, University of California School of Medicine, San Francisco, Calif., USA 
Key Words. Penile erection · Acetylcholine · Muscarinic · Nicotinic · Acetylcholinesterase · 
Neurotransmitter · Neurostimulation 
Abstract. In 15 adult dogs, the possible role of acetylcholine as a parasympathetic neurotransmitter in canine penile 
erection was investigated. Intracavernous injection of increasing dosages of acetylcholine (0.1-100 μg) induced a 
dose-dependent erectile response with increased arterial flow, cavernous smooth muscle relaxation, and venous 
occlusion. This erectile response was completely abolished after muscarinic blockade by intracavernous injection of 
0.1 mg atropine. After cavernous nerve stimulation, atropine injection significantly reduced the pudendal arterial flow 
(by 25%) and likewise caused a significant reduction in cavernous outflow restriction. Histologic staining showed 
acetylcholinesterase-positive fibers around the cavernous arteries and within the cavernous erectile tissue. 
By means of descriptive anatomy, Kölliker [18] postu-
lated in 1852 that penile erection is due to arterial relax-
ation with subsequently increased arterial flow, cavernous 
smooth muscle relaxation and restriction of venous drain-
age. In 1863, Eckard [10] was the first to examine the 
phenomenon of canine penile erection functionally by 
galvanic stimulation of the nervi erigentes. He showed 
these nerves to be parasympathetic, emerging from SI to 
S3. Since then, these findings have been reproduced in 
different species [ 1 , 2, 7, 9, 14, 19, 20, 22, 24]. 
According to the classic theory o f autonomic parasym-
pathetic neurotransmission [11], acetylcholine (ACh) has 
been postulated as the neurotransmitter for penile erec-
tion. Over a century ago, Anrep and Cybulsky [3] re-
ported that erection is atropine-resistant and Nikolsky 
[22] found that erection induced by stimulation of the 
nervi erigentes could be abolished by atropine. Neverthe-
less, the question of the atropine-sensitivity of erection 
remains, with in vivo studies yielding results that are 
both contradictory [5, 7, 14, 27] and confirmatory [9, 24]. 
1 Dr. Stief was sponsored by a grant from the Deutsche For-
schungsgemeinschaft. 
In vitro findings have also been conflicting: no effect [4, 
8]; relaxation [6, 13] or contraction [17] of the cavernous 
smooth muscle, and inconsistent effects [1]. 
The aim of this study was to elucidate the role of ACh 
in canine penile erection in vivo. 
Materials and Methods 
In 15 adult male mongrel dogs (21-34.5 kg), anesthesia was 
induced by subcutaneous injection of acepromazine (5 mg/kg body 
weight) and ketamine (0.5 mg/kg body weight) and maintained by 
intravenous infusion of sodium pentobarbital (approximately 1 
mg/kg body weight/h). Systemic blood pressure was monitored via a 
cannula in the femoral artery. 
With the animal in the supine position, the abdominal cavity 
was exposed via a mid-line incision. An ultrasonic flow probe 
(Transsonic Systems Inc., N.Y.) was placed around the right internal 
pudendal artery to measure the arterial blood flow to the penis. In 9 
dogs (No. 7-15), the cavernous nerves were identified by neuro-
stimulation with a prick electrode (Avery Laboratories), caudal to 
their branching from the pelvic nerve. A bipolar cuff electrode (Av-
ery Laboratories) was placed around the cavernous nerve bundles 
bilaterally. Penile erection was induced with an Avery Stimulator 
(0.6-1.2 V, 20 Hz; pulse duration 1 ms; stimulation time 1 min). 
The penis was dissected in all dogs, exposing both corpora cav-
ernosa from the pubic bone to the prepuce. For intracavernous pres-
sure recording (Grass Polygraph, Model 7), a 21-gauge scalp-vein 
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Fig. 1. Apparatus for protocol. Erection 
was induced by cavernous nerve stimula­
tion or intracavernous injection of ACh. 
Arterial response was measured by 
Doppler analysis of the distal pudendal ar­
tery. Venous occlusion was measured by 
cavernous perfusion with clamped aorta, 
and intracavernous pressure was recorded 
via a needle inserted into the cavernous 
body. 
Table 1. Canine erectile response to intracavernous injection of acetylcholine (ACh) 
ACh Pudendal arterial flow1 Intracavernous pressure2 
μ% 
maximum increase duration of inicrease3 maximum increase duration of increase 
ml/min s cm H 2 0 s 
0.1 
1 
10 
100 
2-4 (2.8) 
3.5-7 (4.4) 
4 - 7 (5.8) 
5- 13(11) 
55-90 (77) 
90-300 (141)) 
165-310 (229)) 
385-610 (452)) 
28-60 (49) 
45-112 (72) 
52-124 (91) 
104-144(127) 
50-120 (96) 
90-310 (169) 
180-360 (245) 
360-540 (443) 
All values depict the range, with the mean in parentheses. 
1 Baseline pudendal arterial flow = 6.4 ml/min (4-10 ml/min). 
2 Baseline intracavernous pressure = 20 cm H2O (12-32 cm H2O). 
3 Values represent entire duration of increase, both maximal and rmoiderate elevations, before return to baseline. 
needle was inserted proximally into each cavernous body and con­
nected to a Statham transducer (Model P23). To evaluate the caver­
nous outflow system without the influence of arterial flow, the aorta 
was dissected for occlusion with a Satinsky clamp proximally to the 
branching of the external iliac arteries. For continuous cavernous 
perfusion, a 19-gauge scalp-vein needle was inserted distally into 
each cavernous body and connected to a Harvard perfusion pump. 
Anticoagulation was achieved by 1,000 U sodium heparin intrave­
nously and maintained with 50 U/h (fig. 1). 
Intracavernous Injection of ACh 
Increasing dosages of ACh (0.1, 1 [5 X 10- 9 mol], 10 and 100 
Miocholine, Cooper Vision, Puerto Rico) were injected into the 
right cavernous body, with an interval of 15 min between each injec­
tion. To verify reproducibility, the injection protocol was then 
repeated on the left cavernous body. 
Venous Study after Intracavernous Injection of ACh 
To study the cavernous outflow, the aorta was clamped and 
Sialine solution (37 °C) was perfused intracavernously at constant 
rates of 3.8, 7.6, 15.3 and 26.6 ml/min. Each perfusion was deliv­
ered at 1, 3 and 5 min after clamping the aorta, with a 15-min inter­
nal allowed before increasing the perfusion rate. Perfusions lasted 
ffor 1 min or until the intracavernous pressure surpassed 180 cm 
H 2 0 (out of scale). The perfusion study was then repeated with the 
iintracavernous injection of 100 μg ACh 30 s after clamping the 
aorta. 
Intracavernous Injection of ACh after Muscarinic Blockade 
After intracavernous injection of 0.1 mg atropine (1.44 Χ 10 - 7 
rmol), increasing dosages of ACh (0.1, 1, 10 and 100 μg) were 
iinjected intracavernously with an interval of 3 min between each 
iinjection. 
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Fig. 2. Erectile responses to intracavernous in­
jection of ACh at different doses (0.1-100 μg). For 
1 μg, the flow response is also shown. 
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Effect of Muscarinic Blockade on Neurostimulation-Induced 
Erection 
To study the effect of muscarinic blockade on neurostimulated 
erection, 0.1 mg atropine was injected in dogs 7-12 after five con-
trol stimulations with recordings of internal pudendal arterial and 
intracavernous pressure. One minute after the injection of atropine, 
five more erections were induced by neurostimulation. The interval 
between each neurostimulation was 5 min. 
Effect of Muscarinic Blockade on Neurostimulation-Induced 
Cavernous Outflow Occlusion 
To study the influence of muscarinic blockade on the cavernous 
outflow in neurostimulated erections, a venous study was performed 
in dogs 13-15. After clamping the aorta, the cavernous nerve was 
stimulated at 30 s; at 50 s, the cavernous body was perfused with 
saline solution (37 °C) at the rate of 3.8 ml/min until the intracav-
ernous pressure reached 180 cm H 2 0 . This control study was 
repeated four times. It was then performed five times after intracav-
ernous injection of 0.1 mg atropine. 
Histologic Staining for Acetylcholinesterase 
At the end of the study, the aorta was clamped in 7 dogs (No. 
1-7) and the distal aorta was perfused with 2 liters of saline to wash 
out the erythrocytes from the cavernous spaces. The cavernous bod-
ies were then removed, frozen in liquid nitrogen and processed for 
acetylcholinesterase (AChE) staining [12]. 
Analysis of Data 
Statistical analysis was performed with the Student's t test. 
Results 
Intracavernous Injection of ACh 
The intracavernous injection of ACh into the right 
cavernous body led to an immediate increase in flow i n 
the right pudendal artery, followed by a moderate eleva-
t ion in flow throughout erection. The rise in cavernous 
pressure followed the arterial flow increase after a delay 
of 8-14 s. The ini t ia l strong increase i n intracavernous 
pressure had a dose-dependent duration (from a mean o f 
14 s after 0.1 μg ACh to a mean of 84 s after 100 μg ACh; 
table 1) and then rebounded to moderately elevated lev­
els (fig. 2). The intracavernous injection of ACh into the 
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left cavernous body induced comparable responses in 
the intracavernous pressure, but no significant changes 
in arterial flow within the right pudendal artery. 
Injections of ACh ( < 10 μg) had no effect on systemic 
blood pressure. In 5 of 6 dogs, the injection o f 100 μg 
lowered the blood pressure from a mean of 160/130 to 
120/70 mm Hg for 15-20 s. 
Venous Study after Intracavernous Injection of ACh 
After clamping the aorta, saline perfusion alone of the 
cavernous body induced a rise in intracavernous pres­
sure that plateaued after 11-16 s (fig. 3). The mean pres­
sure at this plateau was 32 cm H 2 0 at a flow rate of 3.8 
ml/min, 45 cm H 2 O at 7.6 ml/min, 65 cm H 2 0 at 15.3 
ml/min and 87 cm H 2 O at 26.6 ml/min. 
After intracavernous injection of 100μg ACh, the 
first perfusion (1 min after clamping the aorta) increased 
the intracavernous pressure to above 180 cm H 2 0 at all 
flow rates in all dogs, indicating cavernous outflow 
occlusion by ACh. At the second perfusion (min 3), 
venous occlusion (intracavernous pressure > 180 cm 
H 2 0 within 60 s of perfusion) occurred in all dogs with 
perfusion rates of 15.3 and 26.6. ml/min. At the third 
perfusion (min 5), venous occlusion was found only in 1 
dog in response to the perfusion rate of 26.6 ml /min . 
Intracavernous Injection of ACh after Muscarinic 
Blockade 
After the intracavernous injection of 0.1 mg atropine, 
ACh had no effect on pudendal arterial flow or intracav­
ernous pressure, regardless of the dosage. 
Effect of Muscarinic Blockade on Neurostimulation-
Induced Erection 
Control neurostimulation of the right cavernous 
nerve induced a full erection in all 6 dogs, wi th a mean 
maximal intracavernous pressure increase o f 117.9cm 
H 2 0 (range 88-140) above baseline (table 2). A pressure 
increase of 60 cm H 2 O was reached after a mean of 
18.5 s (range 10-22) after the beginning o f stimulation; 
an increase of 80 cm H 2 0 required a mean o f 31.2s 
(range 14-76). The mean maximal flow increase after 
neurostimulation was 33.5 ml/min (range 30-38). 
After muscarinic blockade, the mean maximal intra­
cavernous pressure increase was 117.9cm H 2 0 (range 
100-128) above baseline. A pressure increase o f 60 cm 
H 2 0 was reached after a mean of 27.3 s (range 16-36) 
from the beginning of stimulation. At the end o f the 
study (i.e. at the fifth stimulation), the time required to 
attain this level was 39.2 s (range 24-72). The mean 
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Fig. 3. Top: With the aorta clamped, saline perfusion showed no 
venous occlusion. Middle: After l00μg ACh intracavernously. ve­
nous occlusion was found l min after injection of a perfusion rate of 
3.8 ml/min. Bottom: 3 min after intracavernous injection of 100 μ% 
ACh, venous occlusion could be induced by perfusion rates of I 5.3 
ml/min and greater. 
maximal flow increase after neurostimulation was 24.9 
ml/min (range 21-32). 
The reduction of the maximal flow increase by 25% 
after atropine was statistically significant (p < 0.001), as 
was the prolongation after atropine of the time required 
for the intracavernous pressure to attain a landmark 
level (40, 60, 80 cm H 2 0 ) . The maximal intracavernous 
pressure levels were not significantly different before 
and after atropine (p = 0.99). Likewise, there were no 
significant differences between the times required for the 
intracavernous pressure to drop back to landmark levels 
before and after atropine. 
Effect of Muscarinic Blockade on Neurostimulation-
Induced Cavernous Outflow Occlusion 
After clamping the aorta, neurostimulation and sub­
sequent cavernous perfusion of 3.8 ml/min, the intracav­
ernous pressure reached 180 cm H 2 0 after a mean perfu­
sion time of 24.5 ± 1.9 s. After muscarinic blockade, 
this time increased to 34.4 ± 3.9 s (p < 0.001). 
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>>" ... 
Fig. 4. Histologic staining revealed fibers % V ^ ; f e -
positive For AChE around the cavernous artery ^ ^ *' 
(a) and within the cavernous smooth muscle ^ x . 
(b). Magnification X 400 and X 100, respec­
tively, before reduction. 
Table 2. Effect of intracavernous injection of 0.1 mg atropine on neurostimulation-induced canine penile erection 
Pudendal arterial flow Time (s) needed to reach intracavernous pressure increase Maximal 
ml/min intracavernous 
+ 40 + 60 + 80 pressure 
cm H 2 0 cm H 2 0 cm H 2 0 cm H 2 0 
Before atropine 33.5 ±3.9 15.4±3.0 18.5±4.0 22.6±4.9 117.9±12.4 
After atropine 24.9 ±2.8* 22.5 ± 4 . 3 * 27.3 ±5.4* 31.3±6.1* 117.9 ±6.7** 
*p < 0.001; ** ρ > 0.05. 
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Histologic Staining for AChE 
Fibers positive for AChE were found in all dogs 
around the cavernous artery, within nerve bundles near 
the cavernous arteries, and within the cavernous erectile 
tissue (fig. 4). 
Discussion 
Our findings show that intracavernous injection of 
ACh in the canine induces a dose-dependent erectile 
response (e.g. increased arterial flow, relaxation of the 
cavernous smooth muscles, and venous occlusion). This 
response was completely abolished after muscarinic 
blockade by intracavernous atropine. Thus, the induc­
tion of erection by intracavernous ACh represents a 
muscarinic effect in the canine model; in contrast, in 
men and monkeys intracavernous ACh also has a nico­
tinic (ganglionic) effect both in vi tro [1] and in vivo [25]. 
In the present study, the neurostimulation-induced erec­
tion was only modulated, but was not abolished, by the 
intracavernous injection of atropine. A significant reduc­
tion in arterial flow delayed the time required for the 
intracavernous pressure to attain maximal levels. The 
venous study during neurostimulation showed reduced 
cavernous outflow restriction after atropine, indicating 
less complete cavernous smooth muscle relaxation [15] 
than during neurostimulation without previous musca­
rinic blockade. 
The above findings suggest that the role of ACh in 
canine penile erection resides i n its effect on the caver­
nous artery and cavernous smooth muscle. This is sup­
ported by the histologic studies showing AChE-positive 
staining around the cavernous artery and within the cav­
ernous erectile tissue. 
Our results are in accordance wi th those of other in 
vivo studies; Valji and Bookstein [26] have described 
penile erection in the dog after intracavernous injection 
of ACh; Dorr and Brody [9] and Andersson et al. [2] have 
shown that atropine significantly reduces the canine 
erectile response to neurostimulation; and McConnell et 
al. [21] and Shirai et al. [23] have reported AChE-posi­
tive fibers around the cavernous artery and wi th in the 
cavernous erectile tissue i n men, monkeys, cats, rabbits 
and dogs. 
I n contrast, no erectile response has been observed 
after intra-aortic injection o f ACh [14]. This may be due 
to the immediate inactivation o f ACh by AChE in the 
blood, to the pronounced lowering o f the systemic blood 
pressure in response to high doses o f ACh, or to the fact 
that these investigators recorded the pressure in the 
glands rather than in the cavernous bodies. In another 
study, Carati et al. [7] administered high doses (>f atro­
pine (1 mg/kg body weight), but found no effect on the 
erectile response to pelvic nerve stimulation. We think 
that this may be due to the systemic application of atro­
pine. The muscarinic blockade for erection may be more 
complete, even after much smaller doses, when atropine 
is injected directly into the cavernous body instead of 
into the systemic circulation. 
The canine cavernous erectile tissue is reportedly 
relaxed by ACh [6], as are human cavernous tissue strips 
[13]. These two in vitro studies supporting our in vivo 
findings are at variance with the in vitro results of other 
investigators, who have reported both no effect of ACh 
on human cavernous smooth muscle strips [4, 21] and 
inconsistent effects [1]. In muscle strips of different spe­
cies, about a third showed contraction after application 
of ACh [17]. These differences may have several expla­
nations: to prove a relaxing effect, the smooth muscle 
must first be contracted by electrical or pharmacologic 
means. In those studies where this was done before the 
application of ACh, a relaxing effect was shown. Incon­
sistent effects may be due to simultaneous nicotinic and 
muscarinic stimulation in the cavernous tissue of mon­
keys and men. Finally, the action of ACh may depend on 
the integrity of the cavernous endothelium, releasing the 
endothelium-releasing factor that is responsible for the 
effect of ACh on erection [Goldstein I . , personal C om-
mun.]. A destruction of the cavernous endothelium dur­
ing tissue preparation could prevent any subsequent 
effect of ACh on the smooth muscle. In conclusion, our 
in vivo results, together with the histologic findings, sug­
gest a possible role for ACh in canine penile erection. 
Further studies are needed to reveal additional neuro­
transmitters responsible for the erectile response to neu­
rostimulation after muscarinic blockade. 
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